OrphanDrug
OrphanDrug
Pharma Knowledge Base

Medsafe Section 29 Special Clinical Circumstances – NZ

Medsafe S29 NotificationMedicines Act 1981 Section 2914 days

Contents

  1. 1. Description & Eligibility
  2. 2. Countries Using This Pathway

Description & Eligibility

New Zealand Medsafe allows prescribers to obtain and use unapproved medicines for specific patients under Section 29 of the Medicines Act 1981 in special clinical circumstances.

Eligibility Criteria

Serious or life-threatening condition with no locally registered alternative

Legal Reference / Source

Medsafe Section 29 Guidance

Countries Using This Pathway (1)

NZ
New Zealand
NZ
Medsafe Section 29 Special Clinical Circumstances – NZ
Approval FormMedsafe S29 Notification
Timeline14 days
Legal StatusMedicines Act 1981 Section 29
Source Ref.Medsafe Section 29 Guidance
Countries1 countries
Compliance Check
Legal Review3/11/2026
Global ValidityVerified
Medsafe Section 29 Special Clinical Circumstances – NZ — Regulatory Pathway | OrphanDrug